Prof Valentino Bezzerri, PhD is an expert in Biochemistry at Azienda Ospedaliera Universitaria Integrata Verona (Italy). As of October 2026, ScienceLeadR ranks Valentino Bezzerri in the top 1% of experts worldwide for Lipomatosis. Valentino Bezzerri has authored 84 publications, the most recent in 2026. SLR score: 273 (community average: 125). How the SLR is computed.

LeadR Profile

Prof Valentino Bezzerri, PhD Azienda Ospedaliera Universitaria Integrata Verona Italy
273 ScienceLeadR Reputation 273
Network Map

Biochemistry

Subspecialties: Hematology - Pulmonology - Gastroenterology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2014 - 2026

Source: PubMed

Azienda Ospedaliera Universitaria Integrata Verona

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 84

Citations

Citations: 1 735 1st author: 23 Last author: 4 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Theratyping for personalized medicine across cystic fibrosis disease models.
PMID 42928365 — fibrosis, cystic fibrosis, precision medicine, research, therapeutics
Commun Med (Lond)20260
Ecological Patterns of Gut Microbiota During Elexacaftor/Tezacaftor/Ivacaftor Therapy in Cystic Fibrosis.
PMID 42795633 — genes, fibrosis, cystic fibrosis, therapeutics, gastrointestinal microbiome, microbiota
Microorganisms20260
Beyond readthrough: ataluren restores mitochondrial function and reduces oxidative stress in FANCA-mutated cells via mTOR-DRP1 modulation.
PMID 41764196 — cells, stress, physiological, oxidative stress, mutation
Cell Death Discov20260
Hog1/p38 and ZAKα drive Shwachman-Diamond syndrome and provide targets to improve cell growth.
PMID 41684942 — cells, growth, ribosomes, stress, physiological, shwachman-diamond syndrome
bioRxiv20260
Modulation of immune responses by elexacaftor/tezacaftor/ivacaftor therapy in cystic fibrosis: data from a compassionate use program.
PMID 41580795 — cytokines, cells, blood, fibrosis, epithelial cells, respiratory physiological phenomena, cystic fibrosis, immunity, leukocytes, therapeutics
Respir Res20262

LeadR Networks

Main global connection map